Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
MEDIA ALERT: Join Us in San Francisco or Virtually for Data Privacy Day 2017, January 26
-
NVIDIA (NVDA) Appoints Tim Teter EVP/General Counsel
-
Form MA Southwest Stanford Group
-
Form MA-I Southwest Stanford Group
-
NGL Energy Partners (NGL) Names Jared Parker to Board of Directors
-
Harmonic (HLIT) Names Tom Lookabaugh to Board of Directors
-
Amgen (AMGN) Announces Study Results on Parsabiv in sHPT Published in JAMA
-
VIVUS (VVUS) Acquires Tacrolimus and Ascomycin Rights from Selten Pharma for PAH
-
Rad Power Bikes Co-founders Named to Forbes 30 Under 30 List
-
Eiger BioPharmaceuticals (EIGR) First Patient Dosed in Phase 2 LIBERTY Study of Ubenimex in PAH
-
MAXIMUS (MMS) Appoints Gayathri Rajan and Anne Altman to Board of Directors
-
Faro Technologies (FARO) Promotes Robert Seidel to CFO
-
Prothena Corp. (PRTA) Names Carol Karp as Chief Regulatory Officer
-
Pennymac Financial Services (PFSI) CEO Stanford L. Kurland to Assume Role as Executive Chairman; David A. Spector to Become CEO
-
Visteon (VC) Announces Election of James Barrese to Board of Directors
-
Pioneers in Oncolytic Virus and Gene Therapy Fields Announce Formation of IGNITE Immunotherapy Inc., a Company Focused on Oncolytic Cancer Vaccine Discovery and Development
-
Stanford Investment Group to Join Aspiriant
-
Conjoined Twins Successfully Separated at Lucile Packard Children’s Hospital Stanford
-
Radius Health (RDUS) Announces Positive Data from Two RAD1901 Phase 1s in SERD
-
Stanford University Graduates Form New Energy Company to Help Cannabis Industry Go Green
-
Stanford University Reports FY2016 Financial Results
-
AbbVie (ABBV) Announces Presentation of Positive IMBRUVICA Phase 2 Data in cGVHD
-
Janssen Announces Encouraging Data from IMBRUVICA Phase 2 in cGVHD
-
comScore (SCOR) Director Dr. Magid Abraham Resigns
-
Seattle Genetics (SGEN), Takeda Pharma Announce Positive Data from ADCETRIS Phase 3 in CD30-Expressing Cutaneous T-Cell Lymphoma
-
Texas Instruments (TXN) Names Rafael Lizardi as Next CFO; Current CFO, Kevin March, to Retire
-
RTDNA Canada: Recognizing a Lifetime of Achievements
-
Intel (INTC) Outlines AI-Focused Development Strategy
-
Keryx Biopharma (KERX) Announces Ferric Citrate Phase 3 Data in IDA, NDD-CKD: Primary Endpoint Met
-
October Saw a Record Number of Organ Transplants at Lucile Packard Children’s Hospital Stanford
-
Fibrocell Science (FCSC) Names New Chief Medical Advisor
-
Stanford Microbiome Pioneer Elisabeth Bik Becomes New Science Editor at uBiome
-
The Container Store Launches Annual Holiday Hugs Program in Partnership with Children’s Hospitals Nationwide
-
Abeona Therapeutics (ABEO) Announces Publication of Positive EB-101 Phase 1 Data; Says Well-Tolerated in RDEB
-
Stanford sex assault victim named a Glamour woman of the year
-
T. Rowe Price Group (TROW) Announces Planned Retirement of Chairman, CIO Rogers
-
Christopher Contag to Receive SPIE Britton Chance Biomedical Optics Award for Bioluminescence Imaging
-
Family Returns Home to Chicago after 4 Months in Intensive Care Following Infant’s Life-Saving Heart Surgery and Liver Transplant at Lucile Packard Children's Hospital Stanford
-
Myriad Genetics (MYGN) Announces Upcoming Presentations of Strong myPath Melanoma Data
-
Veracyte (VCYT) Announces Significant Data from Percepta Bronchial Genomic Classifier in Lung Cancer Screening
-
INNATE PHARMA : Encouraging initial results for IPH4102 presented at the Third World Congress of Cutaneous Lymphomas
-
NCHL Identifies "BOLD" Organizations That Are Preparing Leaders To Transform Healthcare
-
Cisco Systems (CSCO) Adds Accompany's Chang as Director
-
Stanford Professor Percy Liang, Developer of Google Assistant Core AI Technology Joins Semantic Machines, Inc.
-
Pacific Bio (PACB) to Present SMRT Sequencing Tech Data at ASHG Annual Meeting
-
Abeona Therapeutics (ABEO) Announces Presentation of ABO-102 Phase 1/2 data in MPS IIA
-
Qualcomm (QCOM) Adds Hewlett-Packard's Livermore as Director
-
Adaptimmune Therapeutics (ADAP) Updates on NY-ESO SPEAR at ESMO 2016
-
Resources Connection (RECN) Announces Unanticipated Retirement of CEO Anthony Cherbak Due to Health
-
Advance Auto Parts (AAP) Appoints Tom Okray as CFO, Succeeding Mike Norona

